Evidence map›Paper›PMID 42238766›Full record

ArticleACS catalysis2026

Fast Motions in 5 Alpha Reductase and Its Impact on Enzyme Kinetics.

Rakesh K Roy, Dimitri Antoniou, Steven D Schwartz

Abstract read
In one paragraph

Article in ACS catalysis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Rakesh K RoyDepartment of Chemistry and Biochemistry, The University of Arizona, Tucson, Arizona 85721, United States.
Dimitri AntoniouDepartment of Chemistry and Biochemistry, The University of Arizona, Tucson, Arizona 85721, United States.
Steven D SchwartzDepartment of Chemistry and Biochemistry, The University of Arizona, Tucson, Arizona 85721, United States.ORCID 0000-0002-0308-1059

Funding

Protein dynamics from femtoseconds to milliseconds as crafted by natural and laboratory evolution: towards enzyme designR35GM145213 · NIGMS · UNIVERSITY OF ARIZONA · PI STEVEN D SCHWARTZ · 2022 to 2026
$2.1M
NIGMS NIH HHS R35 GM145213
6 · The paper itself

Abstract

Behind the catalytic efficiency of enzymes lies a finely tuned dynamic interplay among residues that cooperatively orchestrate the reaction. Steroid 5α-reductase type 2 (SRD5A2) catalyzes NADPH-dependent reduction of testosterone to dihydrotestosterone through sequential hydride and proton transfer. Our study addresses fundamental gaps in understanding the catalytic mechanism-activation barriers, rate-promoting dynamics, and electrostatic contributions-none of which have been characterized to date. Using QM/MM simulations with transition path sampling, we have shown how molecular motions can impact the kinetics of a catalytic reaction. We have found that two residues, Tyr33 and L224, have a compression effect on the donor, which not only brings a significant change in the free energy barriers but can also perturb the local electric field, which supports the preorganization theory. Along with that, we have found, through extensive committor analysis, 6 additional residues, Trp53, Arg94, Cys119, Glu197, Phe223, and Arg227, that constitute an extended reaction coordinate network, stabilizing transition states through coupled electrostatic and structural interactions. Analysis of the disease-associated L224P mutant reveals that loss of the L224 compression eliminates field enhancement and increases barriers by 3.3-3.4 kcal/mol, establishing that efficient catalysis requires temporal orchestration of dynamics and electrostatics across the extended protein architecture.

Indexed as

5 alpha reductase catalysiselectric fieldoptimum reaction coordinateQM/MMrate promoting vibrationresidue cross-talktransition path sampling

Identifiers

PMID42238766
PMCPMC13229540

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.